Elhízás: vizsgálatok itt: Argentína
25 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Buenos Aires, Ciudad Autonoma Buenos Aires, Mar del Plata
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Buenos Aires, Ciudad Autonoma Buenos Aires, Mar del Plata
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Buenos Aires, CABA, Ciudad de Buenos Aires, Ramos Mejía, Rosario, San Nicolás
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - 3. fázisTaking peopleA Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Where
- Buenos Aires, CABA, Ciudad de Buenos Aires, Esperanza, Lanus, Mar del Plata, Mendoza, Rosario, San Isidro, SAN M. de Tucuman, San Nicolás de los Arroyos, Santa Fe
- Életkor
- 18 év and over
- People
- 2001 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00 - 3. fázisNot yet taking people in ArgentínaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Buenos Aires, CABA, Capital Federal, Godoy Cruz, Mendoza, Rosario, Santa Rosa, Santiago del Estero
- Életkor
- 18 év and over
- People
- 1408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - 3. fázisTaking peopleEfficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Where
- Buenos Aires, Granadero Baigorria, Rosario, San Fernando, San Isidro, San Juan, SAN M. de Tucuman, San Miguel de Tucumán, San Nicolás
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07353931 · EU 2025-523768-19-00 - 2. fázisTaking peopleA Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Where
- Buenos Aires, Rosario, Santa Fe, Santa Rosa
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07783802 - 3. fázisNot yet taking people in ArgentínaA Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
- Where
- Bahía Blanca, Buenos Aires, Ciudad de Buenos Aires, Córdoba, Del Viso, Godoy Cruz, Granadero Baigorria, Junín, Mar del Plata, Mendoza, Rosario, SAN M. de Tucuman, Santiago del Estero
- Életkor
- 18 év and over
- People
- 2115 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00 - 2. fázisNot yet taking people in ArgentínaA Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes
- Where
- Buenos Aires, Rosario
- Életkor
- 18 év to 75 év
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07890376 - 3. fázisNot yet taking people in ArgentínaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Buenos Aires, CABA, Córdoba, Granadero Baigorria, Lanus, Mar del Plata, Ramos Mejía, Rosario, San Fernando, San Nicolás, Santa Fe
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Buenos Aires, Ciudad de Buenos Aires, Mendoza, Ramos Mejía, Rosario, San Nicolás
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Caba, CABA, Ciudad Autonoma de Buenos Aires, Córdoba, Morón, Ramos Meija, Rosario, San Miguel de Tucumán, San Nicolás de los Arroyos, Santa Fe, Villa María, Zárate
- Életkor
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Buenos Aires, CABA, Ciudad de Buenos Aires, Mendoza, Ramos Mejía, Rosario, San Nicolás
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Buenos Aires, CABA, Capital Federal, Granadero Baigorria, Lanus, Rosario, San Nicolás, San Vicente
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 2. fázisTaking peopleA Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Where
- Buenos Aires, Rosario
- Életkor
- 18 év to 75 év
- People
- 1481 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06143956 - 3. fázisNot yet taking people in ArgentínaA Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
- Where
- Buenos Aires, CABA, Capital Federal, City of Buenos Aires, Ciudad Autónoma de Buenos Aires, Córdoba, Corrientes, Formosa, Godoy Cruz, Godoy Cruz, Mendoza, La Plata, Mar del Plata, Río Cuarto, Rosario, Salta, San Martin, San Miguel de Tucumán, San Nicolás, Santa Fe, Zárate
- Életkor
- 45 év to 64 év
- People
- 8500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00 - 3. fázisTaking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Buenos Aires, CABA, Capital Federal, Ciudad Autónoma de Buenos Aires, Ciudad de Buenos Aires, San Miguel de Tucumán, Santa Fe, Santiago del Estero
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - 3. fázisTaking peopleA Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
- Where
- Buenos Aires, Ramos Mejía, SAN M. de Tucuman
- Életkor
- 12 év to 17 év
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06439277 - 3. fázisTaking peopleAMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
- Where
- Buenos Aires, Córdoba, Esperanza, Santa Fe, Godoy Cruz, San Nicolás, Santa Rosa
- Életkor
- 18 év and over
- People
- 1150 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07339423 · EU 2024-520440-42-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Buenos Aires, Córdoba, Rosario, San Miguel de Tucumán
- Életkor
- 18 év and over
- People
- 1980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - 3. fázisTaking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Buenos Aires, CABA, Capital Federal, City of Buenos Aires, Ciudad Autonoma de Buenos Aires, Córdoba, Esperanza, Santa Fe, Godoy Cruz, Mendoza, Lanús Este, La Plata, Buenos Aires, Pilar, Rosario, Salta, San Miguel de Tucumán, San Nicolás, Santa Fe, Santa Rosa, La Pampa
- Életkor
- 18 év and over
- People
- 5610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - No phaseTaking peopleStudy of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
- Where
- Buenos Aires
- Életkor
- 18 év and over
- People
- 145
- Run by
- Hospital Italiano de Buenos Aires
See details and how to joinNCT07621419 - 2. fázisTaking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- City of Buenos Aires, Corrientes, Lanús Este, Mar del Plata
- Életkor
- 18 év and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00 - No phaseTaking peopleMaternal Characteristics Associated With Child Growth and Adiposity
- Where
- La Plata
- Életkor
- 18 év to 40 év
- People
- 130
- Run by
- Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri
See details and how to joinNCT05798676 - No phaseTaking peopleCardiometabolic Risk Factors Registry
- Where
- Pilar
- Életkor
- 18 év and over
- People
- 25 000
- Run by
- Austral University, Argentina
See details and how to joinNCT04040777